You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
The Authors' reply

https://doi.org/10.1136/gut.2010.237214

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Linked articles 233148.

    • Competing interests Dirk Roggenbuck is a shareholder of GA Generic Assays GmbH and Medipan GmbH. The remaining authors declare that they have no competing financial interests.

    • Patient consent Obtained.

    • Ethics approval This study was conducted with the approval of the Medical Faculty, University of Dresden.

    • Provenance and peer review Not commissioned; not externally peer reviewed.

    Linked Articles